
30/07/2025
Glenn Kerkhof Appointed Interim CEO of Emerald Clinical Trials
Emerald Clinical Trials has appointed long-time Board member and CRO executive Glenn Kerkhof as Interim CEO following Mary Gunn's stepping down as CEO.
Glenn Kerkhof brings over 30 years of industry experience and deep knowledge of Emerald’s strategy and operations.
“We remain focused on strong delivery, client partnerships, and supporting our global teams,” Glenn said.
Full story here - https://bit.ly/CorporateNews_GlennKerkhof